Xiongfei Xu Selected Research

nicotiflorin

9/2006	Neuroprotection of nicotiflorin in permanent focal cerebral ischemia and in neuronal cultures.
8/2006	Nicotiflorin reduces cerebral ischemic damage and upregulates endothelial nitric oxide synthase in primarily cultured rat cerebral blood vessel endothelial cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiongfei Xu Research Topics

Disease

9	Neoplasms (Cancer) 01/2022 - 02/2002
3	Ischemia 11/2022 - 08/2006
3	Adenocarcinoma 05/2021 - 01/2017
3	Bacterial Infections (Bacterial Infection) 10/2016 - 11/2010
3	Infections 05/2015 - 07/2009
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023 - 01/2022
2	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2009
2	Seizures (Absence Seizure) 01/2009 - 01/2008
2	Brain Ischemia (Cerebral Ischemia) 09/2006 - 08/2006
2	Brain Infarction 09/2006 - 08/2006
2	Hypoxia (Hypoxemia) 09/2006 - 08/2006
1	Bites and Stings (Sting) 12/2023
1	Arthritis (Polyarthritis) 12/2023
1	Diabetic Neuropathies (Diabetic Neuropathy) 01/2023
1	Rheumatoid Arthritis 01/2023
1	Diabetes Complications 01/2023
1	Carcinoma (Carcinomatosis) 01/2021
1	Neoplasms, Cystic, Mucinous, and Serous 01/2021
1	Fanconi Anemia (Fanconi's Anemia) 01/2021
1	Fibrosis (Cirrhosis) 01/2020
1	Inflammation (Inflammations) 01/2020
1	Arteriosclerosis 01/2020
1	Metabolic Diseases (Metabolic Disease) 01/2020
1	Hepatomegaly 01/2020
1	Hypersensitivity (Allergy) 01/2011
1	Vesicular Stomatitis 07/2009
1	Septic Shock (Toxic Shock Syndrome) 07/2009
1	Lung Neoplasms (Lung Cancer) 01/2009
1	Hypothermia 02/2002
1	Necrosis 02/2002

Drug/Important Bio-Agent (IBA)

2	InterferonsIBA 12/2023 - 07/2011
2	CytokinesIBA 12/2023 - 05/2015
2	Therapeutic UsesIBA 11/2022 - 01/2022
2	Oxygen (Dioxygen)IBA 01/2009 - 01/2008
2	nicotiflorinIBA 09/2006 - 08/2006
1	Methotrexate (Mexate)FDA LinkGeneric 12/2023
1	Phosphotransferases (Kinase)IBA 12/2023
1	epalrestatIBA 01/2023
1	Aldehyde Reductase (Aldose Reductase)IBA 01/2023
1	erucylphosphocholineIBA 11/2022
1	CateninsIBA 11/2022
1	Glucose (Dextrose)FDA LinkGeneric 11/2022
1	Streptozocin (Streptozotocin)FDA Link 11/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2022
1	QuercetinIBA 01/2022
1	ChromatinIBA 01/2022
1	kaempferolIBA 01/2022
1	sclareolIBA 01/2022
1	isoimperatorinIBA 01/2022
1	girinimbineIBA 01/2022
1	Vincristine (Oncovin)FDA LinkGeneric 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	CamptothecinIBA 01/2022
1	LuteolinIBA 01/2022
1	vasectrin I (VS I)IBA 05/2021
1	PlatinumIBA 01/2021
1	Polyvinyl Chloride (PVC)IBA 01/2021
1	GlycogenIBA 01/2020
1	FructoseIBA 01/2020
1	Advanced Glycation End ProductsIBA 01/2020
1	ArginaseIBA 01/2017
1	LectinsIBA 10/2016
1	AntigensIBA 10/2016
1	Sialic Acid Binding Immunoglobulin-like LectinsIBA 10/2016
1	MicroRNAs (MicroRNA)IBA 07/2011
1	Interleukin-10 (Interleukin 10)IBA 01/2011
1	Interleukin-17 (Interleukin 17)IBA 11/2010
1	LipopolysaccharidesIBA 07/2009
1	aspartic acid glycine arginineIBA 01/2009
1	Integrin alphaVbeta3IBA 01/2009
1	ferumoxtran-10 (ultrasmall superparamagnetic iron oxide)IBA 01/2009
1	arginyl-glycyl-aspartic acidIBA 01/2009
1	Messenger RNA (mRNA)IBA 08/2006
1	Proteins (Proteins, Gene)FDA Link 08/2006
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 08/2006
1	Neuroprotective AgentsIBA 08/2006
1	Fluorescein-5-isothiocyanate (FITC)IBA 02/2002

Therapy/Procedure

2	Immunotherapy 01/2022 - 01/2017
1	Pancreatectomy 01/2023
1	Transplantation 11/2022
1	Therapeutics 01/2022
1	Precision Medicine 01/2022
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2022
1	Adjuvant Chemotherapy 05/2021
1	Radiotherapy 02/2002
1	Anesthesia 02/2002